SDGR 📈 Schrodinger - Overview

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US80810D1037

SDGR: Software, Simulation, Modeling, Discovery, Molecules, Drugs

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. It has a research collaboration and license agreement with Novartis AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York. Web URL: https://www.schrodinger.com

Additional Sources for SDGR Stock

SDGR Stock Overview

Market Cap in USD 1,577m
Sector Healthcare
Industry Health Information Services
GiC Sub-Industry Health Care Technology
IPO / Inception 2020-02-06

SDGR Stock Ratings

Growth 5y -53.7%
Fundamental -45.7%
Dividend -
Rel. Strength Industry -6520
Analysts 4.27/5
Fair Price Momentum 15.98 USD
Fair Price DCF -

SDGR Dividends

No Dividends Paid

SDGR Growth Ratios

Growth Correlation 3m 76.1%
Growth Correlation 12m -82.1%
Growth Correlation 5y -77.2%
CAGR 5y -7.72%
CAGR/Mean DD 5y -0.13
Sharpe Ratio 12m -0.67
Alpha -69.28
Beta 1.10
Volatility 57.69%
Current Volume 458.8k
Average Volume 20d 590.4k
What is the price of SDGR stocks?
As of January 01, 2025, the stock is trading at USD 19.29 with a total of 458,763 shares traded.
Over the past week, the price has changed by -2.23%, over one month by -14.19%, over three months by +3.99% and over the past year by -45.09%.
Is Schrodinger a good stock to buy?
Probably not. Based on ValueRay Fundamental Analyses, Schrodinger (NASDAQ:SDGR) is currently (January 2025) not a good stock to buy. It has a ValueRay Fundamental Rating of -45.69 and therefor a somewhat negative outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SDGR as of January 2025 is 15.98. This means that SDGR is currently overvalued and has a potential downside of -17.16%.
Is SDGR a buy, sell or hold?
Schrodinger has received a consensus analysts rating of 4.27. Therefor, it is recommend to buy SDGR.
  • Strong Buy: 6
  • Buy: 2
  • Hold: 3
  • Sell: 0
  • Strong Sell: 0
What are the forecast for SDGR stock price target?
According to ValueRays Forecast Model, SDGR Schrodinger will be worth about 17.7 in January 2026. The stock is currently trading at 19.29. This means that the stock has a potential downside of -8.09%.
Issuer Forecast Upside
Wallstreet Target Price 32 65.9%
Analysts Target Price 55.4 187.4%
ValueRay Target Price 17.7 -8.1%